Climb Bio, Inc. CLYM Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Climb Bio, Inc.’s reported figures.
The official record: Climb Bio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Climb Bio, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Climb Bio, Inc.'s invested capital?
- Climb Bio, Inc. (CLYM) reported invested capital of $140.21M in Q1 2026.
- How has Climb Bio, Inc.'s invested capital changed year-over-year?
- Climb Bio, Inc.'s invested capital decreased by 14.9% year-over-year, from $164.84M to $140.21M.
- What is the long-term trend for Climb Bio, Inc.'s invested capital?
- Over 4 years (2021 to 2025), Climb Bio, Inc.'s invested capital has grown at a 0.8% compound annual growth rate (CAGR), from $121.18M to $125.33M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).